USFDA completes inspection at Alembic Pharma’s Solid Oral Oncology facility at Panelav

28 Jun 2019 Evaluate

United States Food and Drug Administration (USFDA) has conducted an inspection at Alembic Pharmaceuticals' Solid Oral Oncology facility located at Panelav from June 24, 2019 to June 28, 2019. This was a first scheduled inspection and company passed the inspection without any Form 483 Observation.

Alembic Pharmaceuticals, a vertically integrated research and development pharmaceutical company, has been at the forefront of Healthcare since 1907.

Alembic Pharma Share Price

839.00 -13.30 (-1.56%)
29-Dec-2025 13:06 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1723.00
Dr. Reddys Lab 1267.30
Cipla 1499.40
Zydus Lifesciences 904.05
Lupin 2095.50
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×